TrialThe oncologist2023

Efficacy and Safety of Avapritinib in Treating Unresectable or Metastatic Gastrointestinal Stromal Tumors: A Phase I/II, Open-Label, Multicenter Study.

Jian Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.